![Houman D. Hemmati](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Houman D. Hemmati
Direttore/Membro del Consiglio presso
Mediprint Ophthalmics, Inc.
Profilo
Houman D.
Hemmati is currently a Director at Noveome Biotherapeutics, Inc. and also holds Director positions at Trailhead Biosystems, Inc. and Mediprint Ophthalmics, Inc. Previously, he was an Advisor at Draper Fisher Jurvetson ePlanet Ventures, a Research Analyst at Griffen-Rose LLC, and a Vice President-Medical & Clinical Development at Capricor Therapeutics, Inc. Hemmati received his undergraduate degree from Stanford University and his doctorate degrees from the University of California, Los Angeles and the California Institute of Technology.
Posizioni attive di Houman D. Hemmati
| Società | Posizione | Inizio |
|---|---|---|
Mediprint Ophthalmics, Inc.
 Mediprint Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes proprietary ocular drug-eluting contact lenses for eye care | Direttore/Membro del Consiglio | - |
Trailhead Biosystems, Inc.
 Trailhead Biosystems, Inc. BiotechnologyHealth Technology Develops cell based therapies | Direttore/Membro del Consiglio | - |
Noveome Biotherapeutics, Inc.
 Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures regenerative medicines | Direttore/Membro del Consiglio | 16/11/2022 |
Precedenti posizioni note di Houman D. Hemmati
| Società | Posizione | Fine |
|---|---|---|
Draper Fisher Jurvetson ePlanet Ventures
 Draper Fisher Jurvetson ePlanet Ventures Investment ManagersFinance DFJ ePlanet seeks to provide superior returns through investments in early-stage information technology and medical device start-ups in Asia and Europe, and in expansion-stage information technology and medical device companies in the US. The firm’s investments are focused primarily on wireless, semiconductor, consumer Internet, life sciences, VoIP, broadband and other emerging services sectors. | Corporate Officer/Principal | - |
| CAPRICOR THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Griffen-Rose LLC
 Griffen-Rose LLC Investment ManagersFinance Provides investment research | Analyst-Equity | - |
Formazione di Houman D. Hemmati
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
96
Relazioni di 1° grado
9
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Draper Fisher Jurvetson ePlanet Ventures
Draper Fisher Jurvetson ePlanet Ventures Investment ManagersFinance DFJ ePlanet seeks to provide superior returns through investments in early-stage information technology and medical device start-ups in Asia and Europe, and in expansion-stage information technology and medical device companies in the US. The firm’s investments are focused primarily on wireless, semiconductor, consumer Internet, life sciences, VoIP, broadband and other emerging services sectors. | Finance |
Griffen-Rose LLC
Griffen-Rose LLC Investment ManagersFinance Provides investment research | Finance |
Noveome Biotherapeutics, Inc.
Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures regenerative medicines | Health Technology |
Capricor Therapeutics, Inc.
 Capricor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative products for the treatment of cardiovascular diseases | Health Technology |
Trailhead Biosystems, Inc.
Trailhead Biosystems, Inc. BiotechnologyHealth Technology Develops cell based therapies | Health Technology |
Mediprint Ophthalmics, Inc.
Mediprint Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes proprietary ocular drug-eluting contact lenses for eye care | Health Technology |
